Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Turning Nature's own processes into design strategies for living bone implant biomanufacturing: a decade of Developmental Engineering

Papantoniou I., Nilsson Hall G., Loverdou N., Lesage R., Herpelinck T., Mendes L.

Narrative Review on Cartilage Damage, published in Adv Drug Deliv Rev (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Adv Drug Deliv Rev (2021)
Reported sample size
—
Source database
Europe PMC
PMID
33290762
PMCID
PMC7839840
DOI
10.1016/j.addr.2020.11.012
Citations
20

Abstract (original English)

A decade after the term developmental engineering (DE) was coined to indicate the use of developmental processes as blueprints for the design and development of engineered living implants, a myriad of proof-of-concept studies demonstrate the potential of this approach in small animal models. This review provides an overview of DE work, focusing on applications in bone regeneration. Enabling technologies allow to quantify the distance between in vitro processes and their developmental counterpart, as well as to design strategies to reduce that distance. By embedding Nature's robust mechanisms of action in engineered constructs, predictive large animal data and subsequent positive clinical outcomes can be gradually achieved. To this end, the development of next generation biofabrication technologies should provide the necessary scale and precision for robust living bone implant biomanufacturing.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Bone and BonesAnimalsHumansTissue EngineeringProstheses and ImplantsComputer Simulation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research